Vicarious Surgical Inc (RBOT) FinancialsRBOTVicarious Surgical Inc

Evaluating the bottom line, Vicarious Surgical Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -148.93%, provide a clear picture of how effectively RBOT converts its operational activities into shareholder value.

In the context of the broader market, RBOT competes directly with industry leaders such as VVOS and ALUR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, RBOT's gross margin of N/A stands against VVOS's 47.41% and ALUR's 49.06%. Such benchmarking helps identify whether Vicarious Surgical Inc is trading at a premium or discount relative to its financial performance.

For Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$11.058M, down -35.30% YoY. EPS declined to -1.86, down -35.86% YoY. Gross margin remained at 0, showing no improvement.